Evidence has shown that chronic active BCR signaling leads to constitutive activation in activated B-cell-type diffuse large B-cell lymphoma (ABC-DLBCL) [24], and BCR signaling appears to be a major driver of proliferation in CLL [25], MCL [26], and follicular lymphoma (FL) [27]. This evidence concerns the gene BCR and aneurysmal bone cyst.